Cincinnati Children'S Hospital Medical Center; Division of Rheumatology

Cincinnati, Ohio 45229-3039

0 studies enrolling now · 5 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis — Completed
• A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab) — Completed
• A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) — Completed
• A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed